Invesco Portfolio holdings
Invesco Ltd., founded in 1978 and headquartered in Atlanta, Georgia, is a global investment management firm managing hundreds of billions in assets across a diverse range of products, including mutual funds, exchange-traded funds (ETFs), and institutional portfolios. Known for its blend of active and passive investment strategies, Invesco serves individual investors, financial advisors, and institutions, with a strong presence in North America, Europe, and Asia, bolstered by acquisitions like OppenheimerFunds in 2019. The firm offers specialized solutions in equities, fixed income, real estate, and alternatives, leveraging its global research capabilities to cater to varying market needs. Invesco’s commitment to innovation and client-focused investing has solidified its reputation as a versatile player in the asset management industry.
Top Buys
| 1 |
Invesco S&P 500 Revenue ETF
RWL
|
+$658M |
| 2 |
Tesla
TSLA
|
+$573M |
| 3 |
Bank of America
BAC
|
+$480M |
| 4 |
Amazon
AMZN
|
+$448M |
| 5 |
Canadian Pacific Kansas City
CP
|
+$445M |
Top Sells
| 1 |
Invesco S&P 500 Pure Value ETF
RPV
|
+$493M |
| 2 |
ITCI
Intra-Cellular Therapies Inc.
ITCI
|
+$395M |
| 3 |
Eli Lilly
LLY
|
+$364M |
| 4 |
CME Group
CME
|
+$316M |
| 5 |
T-Mobile US
TMUS
|
+$310M |
Sector Composition
| 1 | Technology | 23.42% |
| 2 | Financials | 13.31% |
| 3 | Industrials | 11.27% |
| 4 | Healthcare | 10.55% |
| 5 | Consumer Discretionary | 10.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
DADA
3451
DELISTED
Dada Nexus
DADA
| $180K | ﹤0.01% |
97,355
+2,217
| +2% | +$4.1K |
|
3452
Definitive Healthcare
DH
$414M
| $179K | ﹤0.01% |
61,871
+10,012
| +19% | +$28.9K |
|
3453
Eletrobras Common Shares
EBR
$19.1B
| $179K | ﹤0.01% |
+25,142
| New | +$179K |
|
3454
Cricut
CRCT
$1.33B
| $177K | ﹤0.01% |
34,389
+11,501
| +50% | +$59.2K |
|
3455
Cardlytics
CDLX
$49.8M
| $177K | ﹤0.01% |
97,054
+24,731
| +34% | +$45K |
|
|
FUND
3456
Sprott Focus Trust
FUND
$246M
| $176K | ﹤0.01% |
23,810
-466
| -2% | -$3.45K |
|
3457
Annexon
ANNX
$252M
| $176K | ﹤0.01% |
91,409
+59,528
| +187% | +$115K |
|
3458
Stoke Therapeutics
STOK
$1.24B
| $174K | ﹤0.01% |
26,183
+14,118
| +117% | +$93.9K |
|
|
NIU
3459
Niu Technologies
NIU
$317M
| $172K | ﹤0.01% |
42,183
+961
| +2% | +$3.92K |
|
3460
Comtech Telecommunications
CMTL
$65.3M
| $171K | ﹤0.01% |
106,692
-32,997
| -24% | -$52.8K |
|
|
ZSPC
3461
zSpace, Inc. Common stock
ZSPC
$40.4M
| $170K | ﹤0.01% |
+22,930
| New | +$170K |
|
3462
Fate Therapeutics
FATE
$115M
| $169K | ﹤0.01% |
213,503
+104,569
| +96% | +$82.6K |
|
3463
PACS Group
PACS
$1.2B
| $169K | ﹤0.01% |
15,001
-954,720
| -98% | -$10.7M |
|
|
JFIN
3464
Jiayin Group
JFIN
$574M
| $168K | ﹤0.01% |
+12,196
| New | +$168K |
|
|
AOMR
3465
Angel Oak Mortgage REIT
AOMR
$232M
| $167K | ﹤0.01% |
+17,514
| New | +$167K |
|
3466
Voyager Therapeutics
VYGR
$231M
| $164K | ﹤0.01% |
48,540
+24,368
| +101% | +$82.4K |
|
3467
Monte Rosa Therapeutics
GLUE
$296M
| $164K | ﹤0.01% |
35,346
+22,499
| +175% | +$104K |
|
|
ALMS
3468
Alumis Inc. Common Stock
ALMS
$447M
| $164K | ﹤0.01% |
+26,680
| New | +$164K |
|
3469
Amylyx Pharmaceuticals
AMLX
$1.05B
| $162K | ﹤0.01% |
+45,694
| New | +$162K |
|
3470
Terns Pharmaceuticals
TERN
$654M
| $161K | ﹤0.01% |
58,345
+34,945
| +149% | +$96.4K |
|
3471
Copel
ELP
$6.84B
| $161K | ﹤0.01% |
22,007
+308
| +1% | +$2.25K |
|
3472
Ooma
OOMA
$345M
| $161K | ﹤0.01% |
+12,287
| New | +$161K |
|
3473
Inotiv
NOTV
$47.8M
| $158K | ﹤0.01% |
71,681
+10,742
| +18% | +$23.7K |
|
|
SUNS
3474
Sunrise Realty Trust, Inc. Common Stock
SUNS
$148M
| $157K | ﹤0.01% |
14,191
-3,684
| -21% | -$40.8K |
|
3475
Eventbrite
EB
$261M
| $157K | ﹤0.01% |
74,310
+27,055
| +57% | +$57.1K |
|